2004•Medical Journal of National Defending Forces in Northwest ChinaRequires access

Therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure

Jinlin Su

Open publisher page 0 citations

Abstract

Objective:To evaluate the therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure(CHF).Methods: 96 patients with CHF were randomly divided into group A ( n =46) who had taken conventional treatment of digitalis and diuretics and group B ( n =50) who were given valsartan (40 to 160 mg·d -1 ) and metoprolol (12.5 to 100 mg·d -1 ) on the conventional therapy.The therapeutic period was 6 months. Results: After treatment,cardiac function (NYHA) improved; blood pressure,heart rate,cardiothoracic ratio,left ventricular diastolic ending diameter (LVDd) and left aurial diameter (LAd) all decreased; left ventricular ejectional fraction (LVEF) increased significantly( P 0.05 ) in group B comparing with those in group A. There were few side effects and patients' tolerance was perfect in Group B.Conclusion:The therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure(CHF) is satisfactory. There are few side effects.

About this research paper

What this paper is about

Objective:To evaluate the therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure(CHF).Methods: 96 patients with CHF were randomly divided into group A ( n =46) who had taken conventional treatment of digitalis and diuretics and group B ( n =50) who were given valsartan (40 to 160 mg·d -1 ) and metoprolol (12.5 to 100 mg·d -1 ) on the conventional therapy.The therapeutic period was 6 months. Results: After treatment,cardiac function (NYHA) improved; blood pressure,heart rate,cardiothoracic ratio,left ventricular diastolic ending diameter (LVDd) and left aurial diameter (LAd) all decreased; left ventricular ejectional fraction (LVEF) increased significantly( P 0.05 ) in group B comparing with those in group A. There were few side effects and patients' tolerance was perfect in Group B.Conclusion:The therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure(CHF) is satisfactory. There are few side effects.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure(CHF).Methods: 96 patients with CHF were randomly divided into group A ( n =46) who had taken conventional treatment of digitalis and diuretics and group B ( n =50) who were given valsartan (40 to 160 mg·d -1 ) and metoprolol (12.5 to 100 mg·d -1 ) on the conventional therapy.The therapeutic period was 6 months. Results: After treatment,cardiac function (NYHA) improved; blood pressure,heart rate,cardiothoracic ratio,left ventricular diastolic ending diameter (LVDd) and left aurial diameter (LAd) all decreased; left ventricular ejectional fraction (LVEF) increased significantly( P 0.05 ) in group B comparing with those in group A. There were few side effects and patients' tolerance was perfect in Group B.Conclusion:The therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure(CHF) is satisfactory. There are few side effects.

Key concepts: Metoprolol, Valsartan, Medicine, Heart failure, Ejection fraction, Cardiology, Internal medicine, Therapeutic effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic efficacy of valsartan accompanied with metoprolol in the patients with congestive heart failure — Research Paper | ScholarLens